Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
Jun 25, 2026, 11:56 AM EST
Restart Life Sciences Market Cap
Restart Life Sciences has a market cap or net worth of CAD 5.19 million as of June 26, 2026. Its market cap has increased by 250.03% in one year.
Market Cap
5.19M
Enterprise Value
4.36M
Revenue
134.55K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since September 22, 2006, Restart Life Sciences's market cap has increased from 4.41M to 5.19M, an increase of 17.85%. That is a compound annual growth rate of 0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 5.19M | -21.52% |
| Dec 31, 2025 | 6.62M | 512.13% |
| Dec 31, 2024 | 1.08M | -63.28% |
| Dec 29, 2023 | 2.94M | -79.49% |
| Dec 30, 2022 | 14.35M | 134.03% |
| Dec 31, 2021 | 6.13M | -74.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 10.88M |
| COSCIENS Biopharma | 8.92M |
| Glow Lifetech | 8.66M |
| Kane Biotech | 6.15M |
| Aptose Biosciences | 5.62M |
| Innovotech | 5.44M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |